Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype

被引：0
|
作者：
G Kristiansen
M Rose
C Geisler
F R Fritzsche
J Gerhardt
C Lüke
A-M Ladhoff
R Knüchel
M Dietel
H Moch
Z Varga
J-P Theurillat
T A Gorr
E Dahl
机构：
[1] Institute of Surgical Pathology,
[2] University Hospital Zurich,undefined
[3] Institute of Pathology,undefined
[4] University Hospital of the RWTH,undefined
[5] Institute of Veterinary Physiology,undefined
[6] Vetsuisse Faculty,undefined
[7] University of Zurich,undefined
[8] Institute of Pathology,undefined
[9] Charité – Universitätsmedizin Berlin,undefined
[10] Institute of Veterinary Physiology,undefined
[11] University of Zurich,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
breast cancer; myoglobin; oestrogen receptor; fatty acids; luminal type;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1736 / 1745
页数：9
相关论文
共 50 条
  • [21] Role of epigenetic modifications in luminal breast cancer
    Abdel-Hafiz, Hany A.
    Horwitz, Kathryn B.
    EPIGENOMICS, 2015, 7 (05) : 847 - 862
  • [22] Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
    Castellanos, Giovanny
    Sebastian Valbuena, Duvan
    Perez, Erika
    Villegas, Victoria E.
    Rondon-Lagos, Milena
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 189 - 211
  • [23] Myoglobin mutant with enhanced nitrite reductase activity regulates intracellular oxidative stress in human breast cancer cells
    Tong, Xin-Yi
    Yang, Xin-Zhi
    Teng, Xinchen
    Gao, Shu-Qin
    Wen, Ge-Bo
    Lin, Ying-Wu
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2022, 730
  • [24] Exogenous and endogenous hormones and breast cancer
    Chen, Wendy Y.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (04) : 573 - 585
  • [25] Endogenous hormones and the aetiology of breast cancer
    Timothy J Key
    Pia K Verkasalo
    Breast Cancer Research, 1 (1)
  • [26] Endogenous estrogens—breast cancer and chemoprevention
    Beata Starek-Świechowicz
    Bogusława Budziszewska
    Andrzej Starek
    Pharmacological Reports, 2021, 73 : 1497 - 1512
  • [27] Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation
    Braganza, Andrea
    Quesnelle, Kelly
    Bickta, Janelle
    Reyes, Christopher
    Wang, Yinna
    Jessup, Morgan
    St Croix, Claudette
    Arlotti, Julie
    Singh, Shivendra V.
    Shiva, Sruti
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (18) : 7269 - 7282
  • [28] Myoglobin Protects Breast Cancer Cells Due to Its ROS and NO Scavenging Properties
    Quinting, Theresa
    Heymann, Anna Katharina
    Bicker, Anne
    Nauth, Theresa
    Bernardini, Andre
    Hankeln, Thomas
    Fandrey, Joachim
    Schreiber, Timm
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide
    Lapcik, Petr
    Sulc, Petr
    Janacova, Lucia
    Jilkova, Katerina
    Potesil, David
    Bouchalova, Pavla
    Mueller, Petr
    Bouchal, Pavel
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2023, 28 (01)
  • [30] Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide
    Petr Lapcik
    Petr Sulc
    Lucia Janacova
    Katerina Jilkova
    David Potesil
    Pavla Bouchalova
    Petr Müller
    Pavel Bouchal
    Cellular & Molecular Biology Letters, 28
12345